About Careers MedBlog Contact us

Pfizer Plans To Raise Bid for AstraZeneca: Media Reports

by Bidita Debnath on May 4, 2014 at 12:28 AM
Font : A-A+

 Pfizer Plans To Raise Bid for AstraZeneca: Media Reports

Media reports reveal that Pfizer plans to increase its bid to acquire AstraZeneca as it seeks to bring the British pharmaceutical giant to the negotiating table.

Pfizer disclosed Monday that AstraZeneca in January rejected an offer of about $99 billion to acquire the British company and that AstraZeneca last weekend rebuffed a second effort to engage in merger talks.


AstraZeneca on Monday said Pfizer's bid "significantly undervalued" the British company.

Reports in financial media, citing unnamed sources, said Pfizer plans to bid $106 billion or thereabouts, with some of the stories saying the pharmaceutical giant could offer a larger share of the offer in cash as opposed to Pfizer stock.

Pfizer declined to comment on the reports.

The biggest US drug maker by revenue has said the deal would combine research pipelines in oncology and other key disciplines. Pfizer also cited the potential for huge spending cuts and a lower tax bill.

Pfizer's attempt to buy AstraZeneca comes amid a wave of deal-making in the pharmaceutical sector as drugmakers face big sales declines due to patent expirations.

Source: AFP


Latest General Health News

 People Living Close to the Seaside Enjoy Better Health
Direct coastal access may represent a viable route to public health promotion, but the relationships of coastal living are not strongest among lower-income groups.
 Over Four Million Gardeners Place Their Hearing in Danger
New research by Tinnitus UK has found that over four million gardeners are putting their hearing capacity at risk this summer without using safety protection.
Breaking the Barrier: Unraveling Mucus Plugs to Save Lives in COPD
Mucus plugs could be targeted to help reduce fatalities from chronic obstructive pulmonary disease.
 Disease Modifying Therapies for Multiple Sclerosis Continue to Drive Up Healthcare Cost
The development of reliable curative therapies for multiple sclerosis could significantly reduce the economic burden of the disease on patients and wider society.
 New Genetic Variant Provides Protection Against Alzheimer's Disease
A genetic variant in a patient protected from autosomal dominant Alzheimer's disease (ADAD) suggests a role for RELN signaling in resilience to dementia.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Pfizer Plans To Raise Bid for AstraZeneca: Media Reports Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests